Stockreport

Surrozen Provides Corporate Update on Clinical Programs

Surrozen, Inc.  (SRZN) 
PDF Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the Phase [Read more]